Patients with refractory neovascular age-related macular degeneration were more likely to experience greater decreases in central foveal thickness when treated with higher doses of aflibercept.
“More specifically, patients are more likely to experience a decrease in central foveal thickness, and thus decreased subretinal fluid, but may not achieve such significant subretinal fluid resolution that would lead to interval extension,” Sidney D. Smith said at the virtual Association for Research in Vision and Ophthalmology meeting.
Smith and colleagues evaluated the effect of increasing
Uncategorized